As of October 2023, the Neurosteroid Intervention for Menopausal and Perimenopausal Depression is no longer recruiting participants at the MGH site.

Are you experiencing symptoms of menopause and feeling depressed or down?

You may qualify for a medication research study at MGH if you are:

  • 40-67 years old
  • Experiencing bothersome hot flashes
  • Experiencing depression or down mood

To participate, patients must be willing to travel to MGH in Boston, MA for three in-person visits. Qualified participants will be asked to participate in 3 in-person visits and 6 virtual visits over 16 weeks, and may be compensated up to $650. All evaluations and medications included as part of this study would be provided at no cost.